BV
Bavarian Nordic A/S
BVNKF · OTC
$27.56 -15.38% (-$5.01)
Market Cap 13.8B kr
P/E Ratio 8.99x
Div. Yield -
ROE 11.88%
Bulios Fair Price
$19
31.1% downside
Current Price
$27.56
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BVNKF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
97 /100
Cheap P/E 8.99x
EV/EBITDA 5.04x
P/S 2.20x
Growth
100 /100
Growing Rev. growth 25.02%
Book val. growth 21.55%
EPS growth N/A
Profitability
100 /100
Strong Gross margin 49.52%
Net margin 24.50%
Op. margin 29.78%
Quality
58 /100
Average ROIC 10.65%
ROE 11.88%
ROA 10.50%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 6.53x
Int. coverage 137.98x
Stability
32 /100
Unstable Beta 0.94x
Rev. volatility 76.14%
EPS volatility 283.85%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BVNKF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul John Chaplin
Employees
1,795
Headquarters
Hellerup
Upcoming events
13 NOV
Earnings
Upcoming earnings report